Deflazacort in Duchenne Muscular Dystrophy
LONDON, March 24, 2016 (PRNewswire)
US Neurology, the peer-reviewed journal, has published an article summarizing the benefits and risks of deflazacort in Duchenne muscular dystrophy.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
LONDON, March 24, 2016 (PRNewswire)
US Neurology, the peer-reviewed journal, has published an article summarizing the benefits and risks of deflazacort in Duchenne muscular dystrophy.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Or use a
.Explore the latest in medical education and stay current in your field. Create a free account to track your learning.